Piet Wigerinck
Director/Board Member at IPSEN
Net worth: 82 961 $ as of 30/04/2024
Network origin in Piet Wigerinck first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
46
| Public Company | Pharmaceuticals: Major | 46 |
32
| Public Company | Biotechnology | 32 |
miDIAGNOSTICS NV
 miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services miDIAGNOSTICS NV develops a computer chip powered portable medical laboratory. The company is headquartered in Leuven, Belgium.
9
| Holding Company | Miscellaneous Commercial Services | 9 |
Atriva Therapeutics GmbH
 Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany.
4
| Holding Company | Biotechnology | 4 |
University Hospital Antwerp
 University Hospital Antwerp Hospital/Nursing ManagementHealth Services University Hospital Antwerp provides clinical, patient care, academic training and scientific research services. The company was is headquartered in Belgium.
3
| Non-Profit Organization | Hospital/Nursing Management | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Piet Wigerinck via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Chief Executive Officer Chairman Chairman Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin Masters Business Admin | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel Director of Finance/CFO | |
| EPIZYME, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member President | |
| Ghent University | College/University | Graduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| UNIQURE N.V. | Biotechnology | Chairman Chairman Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| MITHRA PHARMACEUTICALS S.A. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| ESSEC Business School | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
| Université Paris II Panthéon Assas | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Corporate Officer/Principal Private Equity Investor | |
| SANOFI | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Beech Tree SA
 Beech Tree SA Financial ConglomeratesFinance Beech Tree SA is an investment holding Luxembourger company. The private company is based in Luxemburg, Luxembourg. The company was founded in 2001. The CEO is Antoine Flochel. | Financial Conglomerates | Director/Board Member Chief Executive Officer Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member President | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Interuniversitair Micro-Electronica Centrum VZW
 Interuniversitair Micro-Electronica Centrum VZW Miscellaneous Commercial ServicesCommercial Services Interuniversitair Micro-Electronica Centrum VZW, also known as Imec, is a Belgian business accelerator. The non-profit company is based in Leuven, BE and has subsidiaries in the United States, Taiwan, India, Netherlands, and Belgium. Imec.istart is their main program, which helps startups grow and succeed. The Belgian company was founded in 1984 and has been led by CEO Luc van den Hove since then. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
PricewaterhouseCoopers Corporate Financ SAS
 PricewaterhouseCoopers Corporate Financ SAS Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers Corporate Financ SAS provides business and management consulting services. The company is based in Neuilly-sur-Seine, France and was founded in 2005. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Chief Executive Officer | |
| London School of Economics & Political Science | College/University | Graduate Degree Graduate Degree | |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Tibotec Virco NV
 Tibotec Virco NV Miscellaneous Commercial ServicesCommercial Services Tibotec-Virco NV develops drugs and individualized disease management products. The firm also offers early stage research programs concentrating on the development of treatments for cancer, hepatitis C, and other infectious diseases. The company also provides HIV drug resistance testing and other analytical services in the United States, Japan, Europe, Canada, and Australia. It has operations in Belgium, North Carolina, Ireland, and the United Kingdom. It was founded in by Paul Stoffels in March, 2001 and is headquartered in Mechelen, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
Charles River Discovery Research Services UK Ltd.
 Charles River Discovery Research Services UK Ltd. Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services UK Ltd. provides drug discovery products and services to various pharmaceutical companies. It focuses on three areas such as kinases, G-protein coupled receptors, and ion channels. The company was founded in 1997 and is headquartered in Kent, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer | |
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Medical Specialties | Chief Executive Officer Director/Board Member | |
| Maastricht University | College/University | Graduate Degree Doctorate Degree | |
| Massa Management SARL | Corporate Officer/Principal Corporate Officer/Principal | ||
Ipsen Pharma SA
 Ipsen Pharma SA Pharmaceuticals: MajorHealth Technology Ipsen Pharma SA manufactures and distributes pharmaceutical products. It supplies products to the therapeutic areas such as oncology, endocrinology, and neuromuscular disorders. The firm also develops drugs for gastroenterology, cognitive disorders, and cardiovascular diseases. Ipsen Pharma is headquartered in Sant Feliu de Llobregat, Spain. | Pharmaceuticals: Major | President Director/Board Member | |
| Beech Tree SARL | Director/Board Member Director/Board Member | ||
| Université Catholique de Louvain | College/University | Graduate Degree Doctorate Degree | |
| Georgetown University | College/University | Undergraduate Degree Undergraduate Degree | |
RespiVert Ltd.
 RespiVert Ltd. Medical DistributorsDistribution Services RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom. | Medical Distributors | Chairman Founder | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member Chairman | |
European Biopharmaceutical Enterprises
 European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Biotechnology | Director/Board Member Chairman | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| Columbia Business School | College/University | Undergraduate Degree Masters Business Admin | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Alychlo NV
 Alychlo NV Investment ManagersFinance Alychlo NV is an independent private equity firm founded in 2008 by Marck Coucke.The company is headquartered in Merelbeke, Belgium. | Investment Managers | Chief Executive Officer Corporate Officer/Principal | |
| ESCP Europe Campus Paris | College/University | Undergraduate Degree Corporate Officer/Principal |
Statistics
International
| United States | 15 |
| Belgium | 12 |
| France | 8 |
| Luxembourg | 5 |
| Netherlands | 5 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 14 |
| Commercial Services | 7 |
| Finance | 5 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 486 |
| Corporate Officer/Principal | 214 |
| Chairman | 115 |
| Independent Dir/Board Member | 96 |
| Chief Executive Officer | 95 |
Most connected contacts
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| Pieter Bourgeois | 36 |
| Michèle Ollier | 33 |
| Michel Akkermans | 32 |
| Marc M. P. de Garidel | 31 |
| Vicki Sato | 28 |
| Ferdinand Verdonck | 25 |
| Marc. A. A. A. L Coucke | 25 |
| Antoine Flochel | 24 |
| Alexandre LeBeaut | 22 |
| Urbain Vandeurzen | 20 |
| Harrold van Barlingen | 20 |
| Rudi Pauwels | 19 |
| Daniel O'Day | 19 |
| Christophe Jean | 19 |
- Stock Market
- Insiders
- Piet Wigerinck
- Company connections
